Terns Pharmaceuticals (TERN) Loans and Notes Receivables (2020)
Terns Pharmaceuticals (TERN) has disclosed Loans and Notes Receivables for 1 consecutive years, with $12.7 million as the latest value for Q4 2020.
- For the quarter ending Q4 2020, Loans and Notes Receivables changed N/A year-over-year to $12.7 million, compared with a TTM value of $12.7 million through Dec 2020, changed N/A, and an annual FY2020 reading of $12.7 million, changed N/A over the prior year.
- Loans and Notes Receivables was $12.7 million for Q4 2020 at Terns Pharmaceuticals.
- Across five years, Loans and Notes Receivables topped out at $12.7 million in Q4 2020 and bottomed at $12.7 million in Q4 2020.